[1]
“Spectrum of BCR-ABL Mutations and Treatment Outcomes in Imatinib-Resistant CML Patients: A Retrospective Analysis from a Tertiary Centre in South India”, JOC, vol. 24, no. 4, pp. 261–270, Nov. 2025, doi: 10.64149/J.Carcinog.24.4.261-270.